Abstract
Rationale
Research has demonstrated that psychosocial stressors increase smoking and risk for smoking relapse. Alterations in biological systems involved in the stress response caused by chronic smoking may contribute to early relapse.
Objectives
We examined the extent to which pituitary–adrenocortical and cardiovascular responses to stress following the first 24 h of a quit attempt predict early relapse.
Methods
Seventy-two smokers interested in cessation attended a laboratory stress session 24 h after the beginning of their cessation attempt. Adrenocorticotropin (ACTH), plasma and salivary cortisol concentrations, systolic and diastolic blood pressure (BP), and heart rate (HR) responses to acute psychological stressors (public speaking and cognitive challenges) were used to predict relapse over a 4-week follow-up period.
Results
Those who relapsed within 4 weeks showed attenuated hormonal and cardiovascular responses to stress and exaggerated withdrawal symptoms. Cox proportional hazards survival analysis showed that attenuated ACTH, plasma cortisol, systolic and diastolic BP, positive affect, and exaggerated withdrawal symptoms and smoking urges during acute stress predicted early relapse. Stepwise model showed that ACTH, diastolic BP, and exaggerated withdrawal symptoms remain as significant predictors. When baseline smoking and psychological measures were included in the model, changes in ACTH, diastolic BP, and both factors of smoking urges remained significant predictors of relapse.
Conclusions
These results demonstrate that altered stress response predicts increased vulnerability for smoking relapse.
Similar content being viewed by others
References
al’Absi M, Lovallo WR, McKey B, Pincomb G (1994) Borderline hypertensives produce exaggerated adrenocortical responses to mental stress. Psychosom Med 56:245–250
al’Absi M, Bongard S, Buchanan T, Pincomb GA, Licinio J (1997) Cardiovascular and neuroendocrine adjustment to public speaking and mental arithmetic stressors. Psychophysiology 34:266–275
al’Absi M, Lovallo WR, McKey B, Sung BH, Whitsett TL, Wilson MF (1998) Hypothalamic–pituitary–adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med 60:521–527
al’Absi M, Amunrud T, Wittmers LE (2002) Psychophysiological effects of abstinence and behavioral challenges in habitual smokers. Pharmacol Biochem Behav 72:707–716
al’Absi M, Wittmers LE, Erickson J, Hatsukami DK, Crouse B (2003) Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol Biochem Behav 74:401–410
al’Absi M, Hatsukami D, Davis GL, Wittmers LE (2004) Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 73:267–278
Brown RA, Lejuez CW, Kahler CW, Strong DR (2002) Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol 111:180–185
Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, Miller IW (2002) Patterns of change in depressive symptoms during smoking cessation: who’s at risk for relapse? J Consult Clin Psychol 70:356–361
Cacioppo JT (1994) Social neuroscience: autonomic, neuroendocrine, and immune response to stress. Psychophysiology 31:113–128
Carey MP, Kalra DL, Carey KB, Halperin S, Richards CS (1993) Stress and unaided smoking cessation: a prospective investigation. J Consult Clin Psychol 61:831–838
Christensen N (1994) Effect of psychosocial stress and age on plasma norepinephrine levels: a review. Psychosom Med 56:77–83
Cohen S, Lichtenstein E (1990) Perceived stress, quitting smoking, and smoking relapse. Health Psychol 9:466–478
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396
Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7–16
Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell CR (1990) The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 38:281–287
Dallman M (1993) Stress update: adaptation of the hypothalamic–pituitary–adrenal axis to chronic stress. Trends Endocrinol Metab 4:62–69
Deroche V, Marinelli M, Le Moal M, Piazza P (1997) Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on Glucocortoid levels. J Pharmacol Exp Ther 281:1401–1407
Dressendorfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ (1992) Synthesis of a cortisol–biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 43:683–692
Emmons KM, Weidner G, Lorraine C (1989) Smoking cessation and cardiovascular reactivity to stress. J Behav Med 12:587–598
Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, Covey LS (1988) Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 259:2863–2866
Gronwall D (1977) Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills 44:373
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127
Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294
Hughes J, Hatsukami DK (1998) Errors in using tobacco withdrawal scale. Tob Control 7:92–93
Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB (2002) Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol 70:216–227
Kirschbaum C, Wust S, Strasburger CJ (1992) Normal cigarette smoking increases free cortisol in habitual smokers. Life Sci 50:435–442
Koob GF, Heinrichs SC (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848:141–152
Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–57
Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT (1993) The role of corticotropin-releasing factor in behavioral responses to stress. CIBA Found Symp 172. In: Chadwick DJ, Marsh S, Ackrill K (eds) Corticotropin-releasing factor. Wiley, Chichester, pp 277–295
Kosten TA, Ambrosio E (2002) HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27:35–69
Majewska MD (2002) HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27:5–12
Makino S, Gold PW, Schulkin J (1994a) Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640:105–112
Makino S, Gold PW, Schulkin J (1994b) Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657:141–149
McEwen BS, Sapolsky RM (1995) Stress and cognitive function. Curr Opin Neurobiol 5:205–216
McEwen BS, Stellar E (1993) Stress and the individual: mechanisms leading to disease. Arch Intern Med 153:2093–2101
McNair DM, Lorr M, Droppleman LF (1992) POMS Manual—Profile of Mood Questionnaire. San Diego, Edits
Mills PJ, Dimsdale JE (1992) Sympathetic nervous system responses to psychosocial stressors. In: Turner JR (ed) Individual differences in cardiovascular responses to stress. Plenum Press, New York, pp 33–50
Parrott A (1999) Does cigarette smoking cause stress? Am Psychol 54:817–820
Pavcovich LA, Valentino RJ (1997) Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. J Neurosci 17:401–408
Perkins K, Epstein L, Grobe J, Fonte C (1994) Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmacol Biochem Behav 47:107–112
Petrusz P, Merchenthaler I (1992) The corticotropin-releasing factor system. In: Nemeroff CB (ed) Neuroencocrinology. CRC Press, Boca Raton
Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB (2003) Smoking withdrawal dynamics. II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol 112:14–27
Piazza PV, Le Moal ML (1996) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359–378
Piazza PV, Le Moal M (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Rev 25:359–372
Piazza PV, Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67–74
Pomerleau OF, Fertig JB, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81:61–67
Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
Robledo P, Koob GF (1993) Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav Brain Res 55:159–166
Sherman E, Strauss E, Spellacy F (1997) Validity of the Paced Auditory Serial Addition Test (PASAT) in adults referred for neuropsychological assessment after head injury. Clin Neuropsychol 11:34–45
Shiffman S, Hickcox M, Paty JA, Gnys M, Kassel JD, Richards TJ (1996) Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics. J Consult Clin Psychol 64:993–1002
Spielberger CD, Gorsuch R, Lushene R (1983) State–trait anxiety manual. Consulting Psychological Press, Palo Alto, CA
Swan GE, Ward MM, Jack LM, Javitz HS (1993) Cardiovascular reactivity as a predictor of relapse in male and female smokers. Health Psychol 12:451–458
Swan GE, Ward MM, Jack LM (1996) Abstinence effects as predictors of 28-day relapse in smokers. Addict Behav 21:481–490
Tiffany ST, Drobes DJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467–1476
Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L (1971) Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocr 33:14–21
West R (1994) Beneficial effects of nicotine: reprise. Addiction 89:144–146
Wilkins JN, Carlson HE, Van Vunakis H, Hill MA, Gritz E, Jarvik ME (1982) Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 78:305–308
Wills TA, Sandy JM, Yaeger AM (2002) Stress and smoking in adolescence: a test of directional hypotheses. Health Psychol 21:122–130
Acknowledgements
We thank Deanna Ellestad, Angie Harju, Laurie Franks, Huong Tim, and Jonathan Erickson for assistance with data collection and management. We thank Clemens Kirschbaum of the University of Dresden, Germany, for assistance with the hormonal and cotinine assays. We thank Ron Regal for assistance with data analysis. This research was supported by a grant to the first author from the National Cancer Institute (CA 88272). The first author was also supported by grants from the National Institute on Drug Abuse (DA013435 and DA016351).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
al’Absi, M., Hatsukami, D. & Davis, G.L. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology 181, 107–117 (2005). https://doi.org/10.1007/s00213-005-2225-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-005-2225-3